Immunocytochemistry for the heavy chain of the non‐muscle myosin IIA as a diagnostic tool for MYH9‐related disorders

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British Journal of Haematology

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.2002.03385.xPMID 11918549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).

  2001cited by this paper
• Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome.

  2001cited by this paper
• Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.

  2000cited by this paper
• Myosins: a diverse superfamily.

  2000cited by this paper
• The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1.

  2000cited by this paper
• Inherited giant platelet disorders. Classification and literature review.

  2000cited by this paper
• Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes

  2000cited by this paper
• Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.

  1999cited by this paper
• Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings.

  1998cited by this paper
• Expression of non-muscle myosin isoforms in rabbit myometrium is estrogen-dependent

  1995cited by this paper
• Differential localization of myosin-II isozymes in human cultured cells and blood cells.

  1994cited by this paper
• Sebastian platelet syndrome: A new variant of hereditary macrothrombocytopenia with leukocyte inclusions

  1990cited by this paper
• Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia.

  1985cited by this paper
• A Type of Heterozygous Bernard-soulier Syndrome Autosomal Dominant Macrothrombocytopenia in Italy Is Most Frequently

  year unknowncited by this paper

• Unraveling MYH9-related disease: A case study on misdiagnosis with idiopathic thrombocytopenic purpura, confirmed through genetic

  2024cites this paper
• Genetic classification and confirmation of inherited platelet disorders: current status in Korea

  2020cites this paper
• Rare inherited kidney diseases: an evolving field in Nephrology

  2020cites this paper
• Identifying and Treating Refractory ITP: Difficulty in Diagnosis and Role of Combination Treatment.

  2019cites this paper
• Thrombopoietin Receptor Agonists

  2019cites this paper
• Diagnosis of Inherited and Acquired Platelet Disorders

  2016cites this paper
• Inherited Platelet Function Disorders: Algorithms for Phenotypic and Genetic Investigation

  2016cites this paper
• Transfection of the mutant MYH 9 cDNA reproduces the most typical cellular phenotype of MYH 9-related disease in different cell lines

  2015cites this paper
• Congenital thrombocytopenia with nephritis - The first case of MYH9 related disorder in Serbia.

  2014cites this paper
• Disorders of red cells and platelets

  2014cites this paper
• Chapter 59 – Thrombopoietin Mimetics

  2013cites this paper
• Inherited thrombocytopenias frequently diagnosed in adults

  2013cites this paper
• Normal neutrophil myosin IIA localization in an immunofluorescence analysis can rule out MYH9 disorders

  2013cites this paper
• Il danno epatico è una nuova caratteristica della Malattia MYH9-correlata

  2012cites this paper
• Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome

  2012cites this paper
• Inherited thrombocytopenias

  2012cites this paper
• Nonmuscle myosin heavy chain and histone H3 are intracellular binding partners of lithospermic acid B and mediate its antiproliferative effect on VSMCs.

  2012cites this paper
• Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.

  2012cites this paper
• Mouse models of MYH 9-related disease : mutations in nonmuscle myosin IIA

  2011cites this paper
• Renal manifestations of patients with MYH9-related disorders

  2011cites this paper
• Recent advances in the understanding and management of MYH9‐related inherited thrombocytopenias

  2011cites this paper
• May-Hegglin anomaly in a dog.

  2011cites this paper
• A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect.

  2010cites this paper
• nonmuscle myosin-IIA assembly related disorders disrupt MYH9- Rod mutations associated with

  2010cites this paper
• MYH9 related disease: four novel mutations of the tail domain of myosin‐9 correlating with a mild clinical phenotype

  2010cites this paper
• Heavy chain myosin 9-related disease (MYH9-RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder

  2010cites this paper
• NARRATIVE REVIEW CKD in MYH9-Related Disorders

  2009cites this paper
• Pathologic Quiz Case: Twin Neonates With Thrombocytopenia

  2009cites this paper
• Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells.

  2009influential citation
• MYH9 related disease: A novel missense Ala95Asp mutation of the MYH9 gene

  2009cites this paper
• CKD in MYH9-related disorders.

  2009cites this paper
• Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders.

  2008cites this paper
• Easy Bruising, Cataracts, and Hearing Loss in a 27-Year-Old Female

  2008cites this paper
• Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines

  2008cites this paper
• Hematologic/Oncologic Disorders

  2008cites this paper
• Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion.

  2007cites this paper
• Viscum album agglutinin‐I induces degradation of cytoskeletal proteins in leukaemia PLB‐985 cells differentiated toward neutrophils: cleavage of non‐muscle myosin heavy chain‐IIA by caspases

  2007cites this paper
• Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.

  2006cites this paper
• A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO

  2006cites this paper
• Expression of non-muscle myosin heavy chain in rat heart after immunosuppressive treatment.

  2006cites this paper
• Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: the use of public gene-targeted ES cell resources.

  2006cites this paper
• Le diagnostic des thrombopnies constitutionnelles

  2006cites this paper
• Congenital macrothrombocytopenias.

  2006cites this paper
• Clinical Characteristics of Autosomal Dominant Giant Platelet Syndromes and Mutation Analysis of MYH9

  2006cites this paper
• Pathologic quiz case: twin neonates with thrombocytopenia. May-Hegglin anomaly.

  2005cites this paper
• Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly.

  2005cites this paper
• Dissecting clinical findings: platelet defects segregate independently of deafness and cataract in a family affected by an apparent syndromic form of macrothrombocytopenia.

  2005cites this paper
• Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders.

  2004cites this paper
• A Unique Immunofluorescence Method Promotes Accurate Diagnosis in MYH9 Disorders: A Case Report.

  2004cites this paper
• A unique immunofluorescence method promotes accurate diagnosis in MYH9 disorders: a case report.

  2004cites this paper
• Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.

  2004cites this paper
• Inherited Thrombocytopenias: Molecular Mechanisms

  2004cites this paper
• Immunofluorescence Analysis of Neutrophil Nonmuscle Myosin Heavy Chain-A in MYH9 Disorders: Association of Subcellular Localization with MYH9 Mutations

  2003cites this paper
• for the phenotypes in May-Hegglin anomaly / Fechtner syndrome mutation results in an unstable protein responsible MYH 9 Asp

  2003cites this paper
• MYH9-Related Disease: May-Hegglin Anomaly, Sebastian Syndrome, Fechtner Syndrome, and Epstein Syndrome Are not Distinct Entities but Represent a Variable Expression of a Single Illness

  2003cites this paper
• Biochemical and Immunohistochemical Evidence for a Non-muscle Myosin at the Neuromuscular Junction in Bovine Skeletal Muscle

  2003cites this paper
• Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.

  2003cites this paper
• Sebastian platelet syndrome: a hereditary macrothrombocytopenia.

  2003cites this paper
• Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine.

  2003cites this paper
• Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome.

  2002cites this paper
• Inherited thrombocytopenias: from genes to therapy

  2002cites this paper
• Inherited thrombocytopenias: from genes to therapy.

  2002cites this paper
• 2 Adenoid Cystic Carcinoma

  2002cites this paper
• Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.

  2002cites this paper